REVIEW
|
doi:10.20944/preprints202202.0027.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
neurodegenerative diseases - multiple sclerosis; new therapeutic options for multiple sclerosis and other 24 neurodegenerative diseases. pH in cancer and neurodegenerative diseases - cancer and neurodegeneration as opposed processes - 25 metabolic e
Online: 2 February 2022 (09:42:40 CET)
ARTICLE
|
doi:10.20944/preprints202410.0760.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Immunoglobulins; antibodies; immune response; antibody structure; immunoglobulin function; therapeutic antibodies; immunotherapy; antigen recognition; immune system; B cells; immunoglobulin classification; IgG; IgA; IgM; IgE; IgD; monoclonal antibodies; polyclonal antibodies; antibody engineering; autoimmune diseases; antibody production; immune regulation; immunological memory; antigen-antibody interaction; clinical immunology; molecular immunology; vaccine development; passive immunity; biopharmaceuticals; antibody-mediated immunity; infectious diseases; cancer immunotherapy; inflammation control; immunoglobulin deficiencies; diagnostic antibodies; therapeutic applications in immunology
Online: 10 October 2024 (09:08:58 CEST)
ARTICLE
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Head and Neck Squamous Cell Carcinoma (HNSCC); the Cancer Genome Atlas (TCGA); Survival Analysis; Optimal Cutoff; Surgical Margin; Holistic Cancer Care; Therapeutic Relationship; Mindfulness Meditation; Transcriptomic Analysis; Effect Size; CAMK2N1; CALML5; FCGBP
Online: 7 July 2021 (08:48:26 CEST)
ARTICLE
|
doi:10.20944/preprints202410.0810.v1
Subject:
Public Health And Healthcare,
Public Health And Health Services
Keywords:
tandem mass spectrometry; TMS; pharmaceutical sciences; rational medication use; drug development, quality control; therapeutic drug monitoring; pharmacokinetics; personalized medicine; drug safety; drug metabolism; analytical techniques; active pharmaceutical ingredients; quality assurance; regulatory compliance; drug interactions; personalized therapies; clinical practice; emerging technologies; biopharmaceuticals; nanomedicine
Online: 11 October 2024 (03:04:52 CEST)